Bioventus Inc. ( BVS) - Key Metrics
BVS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.26 | $0.49 | $0.29 | $0.28 |
| 2026Q1 | $1.96 | $0.05 | $0.13 | $0.12 |
| 2025Q4 | $2.37 | $0.22 | $0.57 | $0.56 |
| 2025Q3 | $2.07 | $0.05 | $0.45 | $0.44 |
| 2025Q2 | $2.22 | $0.11 | $0.39 | $0.38 |
BVS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 4.99 |
| 2026Q1 | 0% | 48.27 |
| 2025Q4 | 0% | 8.45 |
| 2025Q3 | 0% | 35.35 |
| 2025Q2 | 0% | 15.39 |
BVS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.85% | 0% |
| 2026Q1 | 1.39% | 0% |
| 2025Q4 | 7.54% | 0% |
| 2025Q3 | 6.65% | 0% |
| 2025Q2 | 5.61% | 0% |
BVS
Price: $12.69
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.77 USD
P/E Ratio: 18.13
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 889.5 million